Kemri Probes Depo-Provera’s Link to High HIV Risk

Kemri Probes Depo-Provera’s Link to High HIV Risk

Kemri Probes Depo-Provera’s Link to High HIV Risk By John Muchangi Kenya Star “Experts say even if the study links Depo to higher HIV risk, it is unlikely to be withdrawn without a viable replacement. While there would be 49 fewer HIV infections per...
Study on Contraceptives and HIV Risk to be Released Mid-2019

Study on Contraceptives and HIV Risk to be Released Mid-2019

Study on Contraceptives and HIV Risk to be Released Mid-2019 By Carol Natukunda Uganda New Vision Dr. Timothy Mastro, a member of the ECHO management committee said they had concluded the study and that findings will be out by mid 2019.       Published:...
ECHO Study Fact Sheet

ECHO Study Fact Sheet

ECHO Study Fact Sheet The Evidence for Contraceptive Options and HIV Outcomes (ECHO) Study is an open-label randomised clinical trial comparing three highly effective, reversible methods of contraception — a progestogen-only injectable called depot-medroxyprogesterone...
Planning for Outcomes (P4O) Model FAQs

Planning for Outcomes (P4O) Model FAQs

Planning for Outcomes (P4O) Model FAQs Frequently asked questions about the P4O model for estimating the impact of removing injectables from the contraceptive method mix.       Published: 2018 Source: FHI360 Back to...